Breast Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Breast Cancer

published 1 month ago by Dr Neil Love

Featuring perspectives from Drs Harold J Burstein and Lisa Carey on the following topics: ER-Positive, HER2-Negative Breast Cancer Introduction (0:00) CDK4/6 inhibitors for ER-positive breast cancer (3:53) Role of PI3K inhibitors for ER-positive metastatic breast cancer (mBC) (13:31) Use of genomic assays for patients with ER-positive breast cancer (17:48) HER2-Positive Breast Cancer Treatment of early-stage disease; role of neoadjuvant therapy (23:35) Management of HER2-positive mBC (27:23) Triple-Negative Breast Cancer Immunotherapy for advanced triple-negative breast cancer (TNBC) (39:30) Neoadjuvant immunotherapy for TNBC (42:59) PARP inhibition for TNBC (48:37) Efficacy of sacituzumab govitecan in TNBC (54:15) CME information and select publications

more episodes from Research To Practice | Oncology Videos